Results 251 to 260 of about 864,749 (292)
Some of the next articles are maybe not open access.

Effect of influenza vaccine on markers of inflammation and lipid profile

Journal of Laboratory and Clinical Medicine, 2005
Despite wide use of the influenza vaccine, relatively little is known about its effect on the measurement of inflammatory markers. Because inflammatory markers such as C-reactive protein (CRP) are increasingly being used in conjunction with lipids for the clinical assessment of cardiovascular disease and in epidemiologic studies, we evaluated the ...
Michael Y, Tsai   +7 more
openaire   +2 more sources

Vaccination markers: designing unique antigens to be added to vaccines to differentiate between natural infection and vaccination

Vaccine, 2005
Some important vaccines, including ones against tuberculosis (Tb) and foot-and-mouth disease (FMD), are not used in many developed countries because there is no simple way to differentiate between vaccine-induced immunity and infection. Eliminating major protein antigens has not succeeded in the cases of Tb, FMD and some other vaccine preparations ...
openaire   +2 more sources

Laboratory markers for over-attenuation of mumps vaccine virus

Vaccine, 1988
The properties of mumps vaccine virus (Leningrad-3 strain) gradually changed upon passaging in quail embryo fibroblasts, the substrate normally used for mumps vaccine production in the USSR. Alterations were extremely noticeable in the over-attenuated (38th passage) virus variant, and involved (a) poor, if any, antibody response in guinea-pigs, (b ...
, Boriskin YuS   +4 more
openaire   +2 more sources

Using Infection Markers as a Vaccine against Malware Attacks

2012 IEEE International Conference on Green Computing and Communications, 2012
Malware is used by criminals for financial gains, espionage and sabotage, and their code and evasion techniques become increasingly complex and sophisticated. This means it takes longer for security researchers to analyse a malware and develop detection and removal routines, increasing the danger of critical systems becoming infected.
André Wichmann, Elmar Gerhards-Padilla
openaire   +1 more source

Immunological Markers of Cancer Vaccine Efficacy and their Clinical Relevance

Biomarkers in Medicine, 2009
As the field of anticancer therapy advances, with a mission to either prevent tumors or improve the quality of life and survival of those affected by the disease, biomarker discovery in oncology is also growing. Since cancer therapy has become a type of personalized medicine, biomarkers are strongly needed in order to identify the right therapy for the
openaire   +2 more sources

[Genetic markers of viral vaccines].

Annali Sclavo; rivista di microbiologia e di immunologia, 1981
This paper deals with virus vaccines and their genetic markers. In particular we have examined four of the attenuated virus vaccines, now in widespread use, prepared in cell cultures, i.e. poliomyelitis, measles, mumps and rubella. The data reported could be of critical value for the evaluation of the safety and the prophylactic activity of the ...
openaire   +1 more source

Overview of marker vaccine and differential diagnostic test technology

Biologicals, 2005
Recent advances in molecular biology, immunology, microbiology, genetics and microbial pathogenesis have lead to the development of a wide variety of new approaches for developing safer and more effective vaccines based on designs such as subunit vaccines, gene deleted vaccines, live vectored vaccines, and DNA mediated vaccines. Technology tools can be
openaire   +2 more sources

Marker vaccines and the impact of their use on diagnosis and prophylactic measures.

Revue scientifique et technique (International Office of Epizootics), 2007
Molecular biology and technical advances in DNA recombination have ushered in a new era in vaccinology. This article examines the recent development of specific marker vaccines and examines the impact of their use on the diagnosis and prevention of major infectious diseases.
Vannier, P.   +7 more
openaire   +2 more sources

EARLY PROTEIN MARKER FOR TOWNE CYTOMEGALOVIRUS VACCINE

The Lancet, 1984
R J, Stevens, D J, Jeffries, A S, Tyms
openaire   +2 more sources

Home - About - Disclaimer - Privacy